SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
Emerging Infectious Diseases · 2023
DOI: 10.3201/eid2906.221755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2023. Verfasst von Grace B Tyson und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Tyson, G. B., Jones, S., Logan, N., McDonald, M., Marshall, L., Murcia, P. R., Willett, B. J., Weir, W., & Hosie, M. J. (2023). SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom. Emerging Infectious Diseases. https://doi.org/10.3201/eid2906.221755
Vancouver
Tyson GB, Jones S, Logan N, McDonald M, Marshall L, Murcia PR, et al. SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom. Emerging Infectious Diseases. 2023. doi:10.3201/eid2906.221755
BibTeX
@article{Tyson2023,
author = {Tyson, Grace B and Jones, Sarah and Logan, Nicola and McDonald, Michael and Marshall, Leigh and Murcia, Pablo R and Willett, Brian J and Weir, William and Hosie, Margaret J},
title = {SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom},
journal = {Emerging Infectious Diseases},
year = {2023},
doi = {10.3201/eid2906.221755}
}
EUVIMED